Hormone Receptor Positive Breast Carcinoma

DBCOND0119681NeoplasmsSkin and Subcutaneous Tissue Diseases

Hormone Receptor Positive Breast Carcinoma is the indication for 1 drug in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Hormone-receptor Positive Breast Cancer · Hormone Receptor-Positive Breast Cancer · Hormone Receptor Positive Breast Cancer · Hormone-receptors Positive Breast Cancer · Hormone Receptor (HR)-Positive Breast Cancer
Classified under
Indicated drugs

Resolves to

Vocabularies
MedDRA10083234UMLSC5243563

What you can answer from here — as of November 01, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
114Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Hormone Receptor Positive Breast Carcinoma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In